Clin Lab. 2020 Dec 1;66(12). doi: 10.7754/Clin.Lab.2020.200207.
Congenital alpha-2 antiplasmin deficiency is a rare, often misdiagnosed coagulopathy that may result in severe hemorrhage. Homozygous patients develop symptomatology in early childhood, while heterozygous individuals may be asymptomatic or bleed profusely following invasive dental procedures, surgery or trauma late in life. Due to the rarity of this entity, we performed an analysis of reported cases of congenital alpha-2 antiplasmin deficiency to share uncommon cases with the medical community, to raise awareness of the condition among clinicians, and to promote better patient management.
To identify relevant studies, PubMed and Science Direct were searched using controlled vocabulary and keywords based on medical subject headings (MeSH). Data of all reported cases of congenital alpha-2 antiplasmin deficiency were extracted and summarized for study setting, patient characteristics, and types of treatments.
Thirty-three publications were identified encompassing one hundred twenty-three patients. This manuscript presents many important clinical conditions that are uncommon and may go undetected by medical personnel. It illustrates the importance of considering alpha-2 antiplasmin deficiency in the work-up of patients who present with a severe bleeding phenotype and may have normal coagulation screening tests. Management of such patients may be challenging especially when the diagnosis of alpha-2 antiplasmin deficiency is not known.
Improved awareness and access to diagnostic tools will contribute to better management of rare co-agulopathies.
先天性 α-2 抗纤溶酶缺乏症是一种罕见的、常被误诊的凝血疾病,可能导致严重出血。纯合子患者在幼年时出现症状,而杂合子患者可能在生命后期因侵入性牙科手术、手术或外伤而出现无明显症状或大量出血。由于这种疾病较为罕见,我们对已报道的先天性 α-2 抗纤溶酶缺乏症病例进行了分析,以便与医学界分享罕见病例,提高临床医生对该病的认识,并促进更好的患者管理。
为了确定相关研究,我们使用基于医学主题词 (MeSH) 的受控词汇和关键词在 PubMed 和 Science Direct 上进行了搜索。提取并总结了所有已报道的先天性 α-2 抗纤溶酶缺乏症病例的数据,包括研究设置、患者特征和治疗类型。
确定了 33 篇文献,共包含 123 例患者。本研究介绍了许多重要的临床情况,这些情况较为罕见,可能会被医务人员漏诊。它说明了在出现严重出血表现且可能正常的凝血筛选试验的患者中,考虑 α-2 抗纤溶酶缺乏症的重要性。由于不了解 α-2 抗纤溶酶缺乏症的诊断,此类患者的管理可能具有挑战性。
提高认识和获得诊断工具将有助于更好地管理罕见的凝血疾病。